Search

  • HOME
  • Search
Original Articles
Short-term Effectiveness of Intravitreal Bevacizumab vs. Ranibizumab Injections for Patients with Polypoidal Choroidal Vasculopathy
Han Joo Cho, Ji Seon Baek, Dong Won Lee, Chul Gu Kim, Jong Woo Kim
Korean J Ophthalmol. 2012;26(3):157-162.   Published online May 22, 2012
Full textFull text    PubreaderPubReader    PDFPDF    
Clinical Characteristics of Polypoidal Choroidal Vasculopathy Associated with Chronic Central Serous Chorioretionopathy
Han Sang Park, In Taek Kim
Korean J Ophthalmol. 2012;26(1):15-20.   Published online January 14, 2012
Full textFull text    PubreaderPubReader    PDFPDF    
Time-Lag between Subretinal Fluid and Pigment Epithelial Detachment Reduction after Polypoidal Choroidal Vasculopathy Treatment
Ju Byung Chae, Joo Yong Lee, Sung Jae Yang, June-Gone Kim, Young Hee Yoon
Korean J Ophthalmol. 2011;25(2):98-104.   Published online March 11, 2011
Full textFull text    PubreaderPubReader    PDFPDF    
The Therapeutic Effects of Bevacizumab in Patients with Polypoidal Choroidal Vasculopathy
Sun Young Lee, June-Gone Kim, Soo Geun Joe, Hyewon Chung, Young Hee Yoon
Korean J Ophthalmol. 2008;22(2):92-99.   Published online June 20, 2008
Full textFull text    PubreaderPubReader    PDFPDF    
Comparative Studys
Optical Coherence Tomography of Idiopathic Polypoidal Choroidal Vasculopathy.
Ho Seok Sa, Hee Yoon Cho, Se Woong Kang
Korean J Ophthalmol. 2005;19(4):275-280.   Published online December 30, 2005
PDFPDF    

Korean Journal of
Ophthalmology

Print ISSN: 1011-8942
Online ISSN: 2092-9382



ABOUT
BROWSE ARTICLES
EDITORIAL POLICY
FOR CONTRIBUTORS
Editorial Office
#1001, Jeokseon Hyundai BD
130, Sajik-ro, Jongno-gu, Seoul 03170, Korea
Tel: +82-2-2271-6788    Fax: +82-2-2277-5194    E-mail: kos@ijpnc.com                

Copyright © 2025 by Korean Ophthalmological Society.

Developed in M2PI

Close layer
prev next